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Abstract 
Adverse in utero and postnatal conditions can increase susceptibility to metabolic syndrome 
(MS). Altered muscle respiration contributes to MS, but the effects of restricted oxygen and 
nutrients in utero on skeletal muscle mitochondria remain unknown. In this study guinea pig 
sows underwent uterine artery ablations mid-gestation, producing fetuses with low birth 
weight (LBW). Soleus muscle was collected near term or at four months of age, from LBW 
and control fetuses and offspring, where the offspring were fed either a Western Diet (WD) 
or a control diet (CD). Soleus muscles from LBW fetuses exhibit lower maximal respiration 
rates than normal birth weight (NBW) sham-surgery controls. Additionally, LBW/CD, 
NBW/WD and LBW/WD adult guinea pigs displayed reduced respiration compared with 
NBW/CD. Cultured C2C12 cells were utilized to better understand independent effects of 
hypoxia and fatty acid saturation upon cellular respiration. Both chronic (5 days) hypoxia and 
palmitate (16:0) reduced respiration compared with normoxia.  
 
Lay Summary 
The environment in which we develop during pregnancy can determine certain aspects of our 
health as adults. Previous studies have identified a correlation between low birth weight, an 
outcome related to intrauterine growth restriction and the development of metabolic diseases 
such as type 2 diabetes and cardiovascular disease later in life. The present study aimed to 
identify a link between an environment low in oxygen and nutrients during pregnancy, which 
is observed in intrauterine growth restriction and metabolic disorders in adulthood. As there 
is a reduced skeletal muscle mass in cases of intrauterine growth restriction and skeletal 
muscle plays an important role in insulin sensing, an important contributor to metabolic 
health, it was chosen as the focus of this study. An intrauterine growth restricted fetal guinea 
pig model was used to determine a link between a poor environment during pregnancy and 
skeletal muscle oxygen consumption. A second study was undertaken where growth 
restricted animals were given either a control or Western diet to determine if a post-natal diet 
further affected skeletal muscle oxygen consumption. Finally, a cell culture model was used 
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to isolate the effects of hypoxia and the common saturated fatty acid palmitate, the mono 
unsaturated fatty acid palmitoleate on skeletal muscle oxygen consumption. Growth 
restricted animals had reduced skeletal muscle oxygen consumption; however, the addition of 
the Western diet did not further reduce oxygen consumption but did reduce oxygen 
consumption in normal birth weight animals. Similarly, hypoxic cultured cells had reduced 
oxygen consumption and the saturated fatty acid reduced oxygen consumption of only cells 
cultured under normal oxygen levels. The monounsaturated fatty acid had no effect on 
oxygen consumption. Discovering this link allows for further studies to be conducted with 
potential treatments. 
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1 Introduction 
 
1.1 Developmental Origins of Health and Disease 
The in utero environment in which a eutherian mammal fetus develops can determine 
pre-dispositions to metabolic diseases later in life. The maternal uterine lining connects to 
the developing fetus’ umbilical cord via the placenta. This organ regulates fetal gas 
exchange, macronutrient supply and carbon dioxide elimination. Oxygen concentration 
and macronutrient supply are two in utero environmental conditions that can affect 
immediate fetal and later life post-partum metabolism. In fact, the association between a 
poor in utero environment and later life development of metabolic diseases has recently 
emerged as a global health concern for humans (Hales and Barker, 2001). The notion that 
the in utero environment could play a role in adult-onset diseases was first entertained by 
David Barker. His hypothesis (deemed the Barker hypothesis) stated that low oxygen and 
nutrient transfer across the placenta can result in increased risk of metabolic syndrome, a 
cluster of risk factors for metabolic diseases such as cardiovascular disease (CVD), type 2 
diabetes and non-alcoholic fatty liver disease (NAFLD), in later life (Barker, 2004). This 
hypothesis led to the investigation of in utero hypoxia and under nutrition as possible 
contributors to such diseases (De Boo and Harding, 2006). 
Many in-depth human population studies, covering a diversity of race and socio-
economic factors, now provide additional support for the advancement of research into 
developmental origins of health and disease (DOHaD) (Villar and Belizán, 1982; Strauss, 
2000; De Boo and Harding, 2006). A poor in utero environment, resulting from poor 
maternal nutrition may lead to reduced oxygen and nutrient transfer across the placenta, 
priming the offspring with a metabolism that is prepared for a similar, nutrient deprived 
environment outside the womb (Glickman, Hanson and Beedle, 2007). Additionally, 
maternal and fetal genetic factors influence placental nutrient and oxygen transfer  
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(Valsamakis et al., 2006). Decreased expression of homeobox genes HLX1 and ESX1L 
(Murthi et al., 2006; Murthi et al., 2006) involved in embryonic proliferation, migration 
and invasion as well as increased placental  a1-antichymotrypsin mRNA (a protease 
inhibitor involved in inflammation) have been linked to IUGR (Chelbi et al., 2012). 
Independent of these factors, however a nutrient and oxygen deficient in utero 
environment is associated with a low birth weight, and is considered crucial to adult-
onset metabolic disorders (Villar and Belizán, 1982; Chatelain, 2000; Cox and Marton, 
2009).  
Negative early-life environmental experiences, such as in utero hypoxia, can cause 
lasting epigenetic perturbations that may underly DOHaD observations (Hales and 
Barker, 2001; De Boo and Harding, 2006; Valsamakis et al., 2006). These chemical 
modifications of the DNA resulting in alterations in gene expression and regulation are 
associated with an increased risk of later life metabolic disorders (Lal et al., 2003; 
Gluckman et al., 2005). Such disorders may not emerge until early adulthood, or until a 
second challenge, such as poor diet or even exercise, is imposed (Valsamakis et al., 2006; 
Reyes et al., 2015), suggesting that an in utero perturbation may impact gene expression 
both during development and after birth. It is not yet clear, however, whether in utero 
reprogramming events are reversible, and specific genes affected in a variety of tissues 
and animal models are topics of current research efforts (Zeng et al., 2013; Iglesias-Platas 
et al., 2014; Venhoranta et al., 2014). Interventions such as N‐acetylcysteine a precursor 
of the antioxidant glutathione, (Herrera et al., 2017) folic acid, (Ding and Cui, 2018) and 
gene therapy (David, 2017) are currently being explored.  
Although the mechanisms underlying the altered regulation of specific genes related to an 
adverse in utero environment are still being identified, the general pattern of low birth 
weight, prioritizing of blood flow to organs such as the brain, heart and adrenal glands, 
and resulting changes in expression of specific genes, is termed the “thrifty phenotype” 
(Neel, 1999; Hales and Barker, 2001). Thrifty phenotype offspring are not simply 
proportionally smaller, but are asymmetrically restricted in growth; they exhibit a larger 
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brain to liver mass ratio and reduced muscle mass (Hales and Barker, 2001). During 
human evolution, it is speculated that “thrifty genes” were selected for when food was 
scarce, and may have primed offspring for a post-natal life where nutrient availability 
was poor (Neel, 1999; Hales and Barker, 2001; Valsamakis et al., 2006). Today, 
however, maternal and post-natal nutrient deficiency are rare in Western societies, and 
offspring that display a thrifty phenotype, often result from a placental insufficiency-
induced oxygen deficient in utero environment (Godfrey and Robinson, 1994). The 
thrifty phenotype is assumed to increase the probability of in utero survival, but 
establishes a mismatch between the nutrient and oxygen ‘poor’ in utero environment, for 
which the fetus was primed, and the nutrient and oxygen rich environment experienced 
after birth. As a result, the offspring is born with a metabolic profile programmed to 
survive in an energy- and oxygen-deficient (hypoxia) environment, but is exposed to an 
environment with sufficient oxygen that is energy dense, especially when exposed to a 
Western Diet (WD). In these instances human post-partum growth rates above average 
(Boersma and Wit, 2013) are often observed (Bol et al., 2009; Coupé et al., 2009; Crume 
et al., 2014). This rapid weight gain in infancy increases the risk of adult-onset obesity 
(Adair et al., 2013). There is; however, a critical period of approximately 1000 days 
where the thrifty phenotype appears to remain plastic (Victora et al., 2010) which 
provides a window for interventions.   
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1.2 Intrauterine Growth Restriction 
 
Placental nutrient and oxygen transfer, genetic growth potential and the maternal 
environment all contribute to mammalian fetal development. Intrauterine growth 
restriction (IUGR) results in a pregnancy where one or more of these factors are 
negatively altered, creating a sub-optimal developmental environment. IUGR is a 
condition in which a fetus’ growth is restricted and is associated with low birth weight 
(LBW) and in some cases, evidence of asymmetrical growth e.g. high brain to liver 
weight ratio (Mitchell, 2001; Bauer et al., 2003; Rosenberg, 2008). Fetuses which fall 
below the 10th percentile for gestational age and sex are deemed small for gestational age 
(SGA), an outcome related to IUGR. Of these births the majority of pathological cases– 
i.e. those related to adult onset metabolic disorders - involve low abdominal 
circumference but normal brain circumference (Peleg  et al., 1998) . A human birth 
weight threshold of 2,500g for IUGR, however, is a crude and somewhat arbitrary 
criterion that does not account for fetuses outside these parameters who have failed to 
reach their genetic growth potential and were perhaps exposed to a suboptimal in utero 
environment (Gale et al., 2006; Mayer and Joseph, 2013; Melamed, 2014). Metabolic 
remodeling as a result of a sub-optimal in utero environment, and associated with later 
life metabolic disorders may therefore affect individuals across all birth weights (Kuzawa 
and Adair, 2003; Gluckman et al., 2009) and there is emerging evidence of long-term 
metabolic dysfunction independent of birth weight (Moore and Davies, 2005; Walsh and 
McAuliffe, 2015). We must then consider additional parameters for classifying growth 
restriction, such as the mentioned brain and abdominal circumferences, blood 
inflammatory markers, differential microRNA expression, as well as ponderal index 
(mass/height3), a measure of thinness, (Peleg, Kennedy and Hunter, 1998; Hales and 
Barker, 2001; Lausten-Thomsen et al., 2014; Thamotharan et al., 2017) in order to 
include those who are a normal birth weight, but may have undergone a reprogramming 
event due to poor in utero conditions. Low birth weight classifications alone fail to 
include offspring of average birth weight who may have been larger under more 
favorable in utero conditions. 
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A well characterized classification of a sub-optimal in utero environment is placental 
insufficiency (PI), which is an idiopathic condition characterized by a reduction in 
maternal blood flow through the placenta. The resultant hypoxia and poor nutrient 
exchange can lead to IUGR (Gagnon et al., 1996; Trudinger and Giles, 1996). PI occurs 
when the placental fails to develop or implant properly, often resulting in a smaller 
surface area for nutrient and oxygen exchange (Salafia, 1997) leading to a hypoxic, 
nutrient-deprived in utero environment (Pardi et al., 2002). Experimentally PI can be 
mimicked using partial ablation of the uterine artery in guinea pigs (Briscoe et al., 2004; 
Turner and Trudinger, 2009). Larger animal models, such as sheep, which are more 
easily probed with oxygen sensors, are excellent models for studying changes in oxygen 
flow in IUGR (Gagnon et al., 1996; Morrison, 2008; Thompson et al., 2011). Other 
animals, such as swine and rats have also been studied to reveal differences in gene 
expression between control and IUGR offspring, which exhibited reduced insulin 
sensitivity (Kind et al., 2003; Ying et al., 2019). Moreover, culturing muscle precursor 
cells, such as C2C12 mouse myoblast cells, under hypoxia can mimic the effects of PI on 
muscle metabolism (Regnault et al., 2010; Yu et al., 2011). 
The pathological outcome associated with PI is IUGR, which can be categorized as either 
symmetrical or asymmetrical. Symmetrical IUGR is typically a result of maternal or fetal 
genetic abnormalities and results in fetuses which are proportionally small relative to the 
average fetus. In asymmetrical IUGR certain organs (brain, heart, adrenal gland) are 
disproportionately large (Peleg et al., 1998). Asymmetrical IUGR may result from a 
number of causes including maternal hypertension, maternal under nutrition and, most 
commonly, placental insufficiency (Pollack and Divon, 1992; Monk and Moore, 2004; 
Valsamakis et al., 2006). As a result of placental insufficiency, fetal blood flow to the 
heart, brain and adrenal glands increases, but blood flow to other organs including the 
liver, kidneys and skeletal muscle (SM) decreases. This pattern results in a small 
abdomen to head size, i.e. the asymmetrical phenotype. The reduced SM mass has also 
been linked to altered insulin sensitivity in adulthood (Phillips et al., 1994; Desai et al., 
1996; Ozanne et al., 2003).  
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1.3 Hypoxia-induced alterations in skeletal muscle 
metabolism  
 
Independent of deficient nutrient transfer, chronic hypoxia in utero is associated with  
IUGR (Kajimura et al., 2006; Rueda-Clausen et al., 2011); pregnancies at high altitudes 
result in higher proportions of IUGR births in human populations that are not adapted to 
such environments (Murphy et al., 1986; Cogswell and Yip, 1995; Semenza, 2000). 
Further studies in chick embryos isolate hypoxia’s modulating role in IUGR, independent 
of the placenta (Giussani et al., 2007; Mehta and Mehta, 2008; Tintu et al., 2009). 
In prolonged hypoxia, hypoxia inducible factor 1-alpha (HIF1-α) accumulates, leading to 
altered tissue metabolism. HIF1-α  is a powerful transcriptional regulator of energy 
metabolism (Lee et al., 2004; J. W. Kim et al., 2006; Denko, 2008) and is degraded under 
normoxic conditions but allowed to dimerize with HIF1-β under cellular hypoxia (Wiener 
et al., 1996; Ladoux and Frelin, 1997; Wenger et al., 1997).  Accumulation of HIF1-α 
attenuates glycolytic input to the tricarboxylic  acid (TCA) cycle through increased 
transcription of pyruvate dehydrogenase kinase 1 (PDK1), which inactivates pyruvate 
dehydrogenase, halting the conversion of pyruvate to acetyl-CoA (Kim et al., 
2006).Overexpression of HIF1-α in otherwise normoxic pregnant mice led to IUGR and 
reduced placental weights compared to controls (Tal et al., 2010), indicating hypoxia as a 
contributor to IUGR, independent of reduced nutrient transfer. HIF1 is also involved in 
up-regulating the transcription of glycolysis enzymes and glucose transporters (J. W. Kim 
et al., 2006; Papandreou et al., 2006; Aragonés et al., 2008) facilitating anaerobic ATP 
production. Further supporting the observed transcriptional effects of HIF1, functional 
assays in human RCC4 cells show reduced oxygen consumption following normoxic 
recovery from chronic hypoxia (Soares et al., 2005; Papandreou et al., 2006). Yet another 
study has identified electron transport chain (ETC) complex I as a more specific target for 
inhibition under hypoxic conditions; HIF-1α induced downregulation of NDUFA4L2, a 
subunit of complex I, lowers oxygen consumption and suppresses complex I activity 
under hypoxia (Tello et al., 2011). 
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1.3.1 Electron Transport Chain 
 
A number of cellular processes, critical to energy metabolism, including angiogenesis 
(the formation of new blood vessels) glucose metabolism, and oxidative phosphorylation 
are regulated by hypoxia (Mu et al., 2001; Pugh and Ratcliffe, 2003; Magalhães et al., 
2005). As oxygen is central to oxidative phosphorylation (OXPHOS), the role of hypoxia 
in IUGR has been chosen as the focus of this study. OXPHOS is an aerobic metabolic 
pathway occurring in the inner mitochondrial membrane. In this pathway exergonic 
reactions of the ETC, including the donating and accepting of electrons, are coupled with, 
and help drive endergonic reactions such as ATP production. The ETC is comprised of 
five main enzyme complexes and a variety of electron donors with oxygen as the terminal 
electron acceptor. The energy released by the donation of two electrons is used to 
transport two protons across the inner mitochondrial membrane, creating an 
electrochemical gradient which can drive the phosphorylation of ADP, producing ATP. 
The five principal enzyme complexes involved in electron transport are NADH 
dehydrogenase (complex I), succinate dehydrogenase (complex II), cytochrome c 
oxidoreductase (complex III), cytochrome c oxidase (complex IV), and ATP synthase 
(complex V; Figure 1.3-1). Each enzyme complex is comprised of a great number of 
proteins that are encoded by both nuclear and mitochondrial DNA.  
Complex I oxidizes NADH to NAD+ while reducing coenzyme Q10, or ubiquinone, a 
coenzyme within the inner mitochondrial membrane. Complex II is the site of succinate 
and FADH2 oxidation and is the secondary entry point of the electron transport chain. 
While complex II oxidizes succinate to fumarate and reduces ubiquinone, unlike complex 
I, the energy released by this reaction is insufficient to transfer of protons into the 
intermembrane space.  
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Following entry into the ETC from either complex I or complex II, the electrons are 
transferred to complex III by ubiquinone. From complex III, cytochrome C transports the 
electrons to complex IV. When stimulated by sufficient concentrations of ADP and 
inorganic phosphate (Pi), complex V uses the proton gradient created by the ETC to 
generate ATP (Figure 1.3-1).  
Under acute hypoxic conditions, glucose metabolism is altered through what is termed 
the Pasteur Effect. With less oxygen available to act as an electron acceptor at ETC 
complex IV, flux through the ETC, as well as ATP synthesis by complex V, slows. As a 
result, fewer NADH molecules are oxidized by complex I. The accumulated NADH 
would decrease glycolytic flux pyruvate (key TCA metabolite), but it can be oxidized by 
lactate dehydrogenase, while converting pyruvate to lactate. As a result, in acute hypoxia, 
glycolysis can continue at high rates without the accumulation of pyruvate, permitting 
some anaerobic ATP production by way of substrate level phosphorylation.  
Figure 1.3-1 Overview of the Electron Transport Chain. Each of the embedded 
complexes are depicted within the inner mitochondrial membrane (IMM), and the 
dissociable carriers’ coenzyme Q and cytochrome C are represented as (Q) and (c) 
respectively. Electron flow is indicated by solid arrows and proton pumping by dashed 
arrows. 
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1.3.2 Myogenesis and adverse in utero environments 
 
As previously mentioned, many fetal organ systems are impacted in situations of PI 
hypoxia. Skeletal muscle mass is greatly reduced in IUGR offspring (Padoan et al., 2004; 
Larciprete et al., 2005), as a result of hypoxic induced cardiac redistribution, suggesting 
that myogenesis likely occurs in a sub-optimal oxygen environment. Hypoxia is strongly 
linked to the IUGR in utero environment and may contribute to the reduction in overall 
terminal differentiation (Di Carlo et al., 2004; Yun et al., 2005) and decreased muscle 
mass thereby linking hypoxia to the thinness component of the thrifty phenotype.  
Skeletal muscle development during embryogenesis can be affected by the in utero 
environment, and in adulthood. Successful myogenesis requires a precise coordination of 
spatial and temporal events. Myogenesis involves the synchronization of a number of 
embryonic and fetal progenitor cells specified by paired box transcription factors Pax3 
and Pax7 respectively 63,64 which results in determination of myofibers. Following 
activation by Pax3/Pax7, fetal and embryonic muscle growth is orchestrated by the 
myogenic regulatory factors (MRF) myogenin, MyoD, Mrf4, and Myf5 which induce 
expression of genes which encode contractile proteins unique to muscle cells (Figure 
1.3).  
Pax 3 and Pax 7 specify embryonic progenitor cells resulting in satellite cells. These are 
later activated through the continued expression of Pax7 with some regulation by Myf5. 
Satellite cell proliferation begins with the expression of MyoD in addition to Pax7 and 
Myf5 regulation, resulting in myoblast formation. Early differentiation into myocytes is 
marked by declined Pax7 and Myf5 expression with increased myogenin expression and 
slowly increasing Mrf4 expression. Finally, the transition from myocytes to myofibers, or 
late differentiation, is regulated by minimal MyoD expression, tapering myogenin 
expression and maximal Mrf4 expression (Figure 1.3-3).  
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Downstream targets of myogenin and MyoD include the transcription factors known as 
myocyte enhancer factors (MEFs): Mef2A, Mef2B and Mef2C. Together, MRFs and 
MEFs activate the transcription of contractile and structural proteins found in myoblasts 
(Blais et al., 2005). Under IUGR conditions expression of MEF2a decreases but MEF2d 
expression increases, with no change in MEF2c (Raychaudhuri et al., 2008). Because 
MEF2 isoform binding with MyoD relates to GLUT 4 transcription (Raychaudhuri et al., 
2008; Zheng, Rollet and Pan, 2012) in addition to fiber type determination (Potthoff et 
al., 2007), IUGR changes in MEF2 expression potentially contribute to increased risk of  
metabolic syndrome. Additionally, post-natal myogenesis is impaired in IUGR offspring 
(Wirfalt et al., 2001; De Blasio et al., 2007) and lean mass and muscle strength remains 
Figure 1.3-2 Embryonic Myogenesis. Determination and differentiation of muscle cells 
regulated by Pax3/Pax7and MRFs MyoD, Myogenin, Mrf4 and Myf5. Transcription 
factor expression is shown as area under the curve. Modified from Benzinger et al, 2012. 
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decreased compared to controls (Aihie Sayer et al., 2004; Inskip et al., 2007; Ylihärsilä et 
al., 2007). 
Moreover, there have been extensive reports studying in vitro differentiation in the C2C12 
Mus musculus cell line under hypoxia (Yun, et al., 2005; Cicchillitti et al., 2012; Slot et 
al., 2014). Although the cells are derived from adult satellite cells, in vitro differentiation 
closely mimics the in utero fetal differentiation process (Messina et al., 2010). Important 
markers of differentiation and cell signaling, necessary for the initiation of determination 
and differentiation, are expressed similarly in utero and in this cell line (Burattini et al., 
2004) making this cell line a useful and tractable experimental model. 
 
1.4 Skeletal Muscle Fiber Type Composition and 
adverse in utero environments 
 
Fiber type composition determines contractile characteristics, oxidative function and 
metabolic capacity of skeletal muscle. There are two ways to classify fiber types: by their 
myosin ATPase type (affecting twitch speed) and their principle mode of generating ATP 
(oxidative, glycolytic or oxidative/glycolytic). Oxidative and glycolytic fibers express 
different isoforms of myosin heavy chain (MHC) and preferentially metabolize different 
substrates in order to produce ATP. Oxidative fibers have a higher concentration of 
mitochondria and use predominantly oxidative phosphorylation to yield ATP, whereas 
glycolytic fibers primarily use anaerobic glycolysis to yield ATP and have fewer 
mitochondria. Muscle fibers can be alternatively categorized as fast-twitch (Type I) or 
slow-twitch (Type II), referring to the speed of which myosin can hydrolyze ATP. Slow-
twitch fibers are primarily oxidative and in humans are referred to as type Ia fibers, 
whereas Type II fibers can be either oxidative-glycolytic (Type IIa) or glycolytic (Type 
IIb). 
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1.4.1 Skeletal muscle fiber composition  
 
Slow and fast muscle fibers originate during fetal development as populations of primary 
(type I MHC) and secondary (type IIa, IIb and IIx MHC) myotubes respectively. Fiber 
type fate is considered plastic; fiber type switching can occur with exercise or diet 
(Simoneau et al., 1985; Schrauwen et al., 2001; Handschin et al., 2007). In disease states, 
for example individuals with type 2 diabetes and insulin resistance, there is a notable shift 
towards more glycolytic fibers (Tanner et al., 2002; Ten Broek, Grefte and Von den Hoff, 
2010; Tello et al., 2011), which is associated with reduced muscle oxygen consumption 
(He et al., 2001; Oberbach et al., 2006). The mammalian target of rapamycin, 
peroxisome proliferator-activated receptor (PPAR)s and PPAR-γ coactivator-1α (PGC-
1α) together regulate fiber type composition and, by extension oxidative capacity. PGC-
1α increases insulin sensitivity by maintaining a larger number of functional 
mitochondria by inducing fiber type switching towards type I and IIa expression.  
The importance of PPARs in normal fetal development is supported by the fact that 
PPARγ knock-out mice are growth-restricted at birth (Gokina et al., 2013). Furthermore, 
the targeted expression of an activated form of PPARβ/δ in the skeletal muscles makes 
mice resistant to obesity by increasing the numbers of oxidative (Type I and IIa) muscle 
fibers (Slot et al., 2014), while the selective ablation of PPARβ/δ induces obesity by 
reducing the oxidative capacity of the muscles (Schuler et al., 2006). PPARβ/δ also 
directly and indirectly regulates genes involved in fatty acid transport and oxidation 
through binding to specific peroxisome proliferator response elements (PPREs) on these 
genes (Narravula and Colgan, 2001). Examples of these genes include Cluster of 
Differentiation 36 or Fatty acid translocase which is involved in fatty acid uptake 
(Schuler et al., 2006; Jans et al., 2012), carnitine palmitoyl transferase 1, involved in the 
mitochondrial transfer of long-chain fatty acids, and the uncoupling protein (UCP-1, -2 
and -3) family (St-Pierre et al., 2003; Cantó et al., 2012). Altered expression of these 
genes directly correlates with insulin resistance, altered fatty acid oxidation, 
intramyocellular lipid accumulation, and mitochondrial damage (St-Pierre et al., 2003; 
Schuler et al., 2006; Jans et al., 2012). 
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Studies of pig and sheep, which have similar muscle differentiation to humans, show that 
differentiation occurs near mid-gestation and fiber type ratios are set before birth. As 
fiber type determines oxidative capacity, the ratio of oxidative to glycolytic fibers is an 
important factor in predisposition to metabolic syndrome. In human studies, reduced 
PGC-1α mRNA in adult skeletal muscle has been linked to the development of insulin 
resistance and Type II diabetes, in conjunction with inactivity and nutrient excess 
(Handschin et al., 2007; Holmstrom et al., 2012; Kristensen et al., 2014). Further, in 
IUGR rats, fetal PGC-1α promoter activation and expression is impaired, through 
epigenetic modifications (Zeng et al., 2013). These changes are related to the 
development of insulin resistance later in postnatal life and intriguingly also in later 
generations, supportive of the concept of in utero inter-generational programmed PPAR 
modifications (Martins et al., 2012; Shen et al., 2018). These data suggest that adverse 
PGC-1α/PPAR control promotes altered muscle fiber determination and oxidative 
function, which may have inter-generational effects.  
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1.5 The Western Diet 
 
1.5.1 Western Diet origin and composition and the development of 
metabolic disease 
 
Metabolic disorders, many of which exhibit reduced skeletal muscle oxygen consumption 
and altered fiber type composition, are associated with long term consumption of the 
high-fat, high-sugar Western Diet (WD) in adults (Wirfalt et al., 2001). Though diet has 
long been the focus of research in metabolic disorders, emerging data suggest the in utero 
environment plays a role as well (Valsamakis et al., 2006; Nevin et al., 2018). On an 
evolutionary time-scale, agriculture and industrialization are recent developments, which 
have caused extreme changes in the human diet over a short time span. Modern 
technology and urbanization have drastically altered not only nutrient composition but 
also food availability, changing quality and quantity of the human diet. Pre-agricultural 
human populations, or hunter-gatherers, did not have a consistent diet but rather one 
which varied by climate, location and ecological surroundings (Cordain et al., 2000a). 
While their diets varied by location and food availability, many similarities among the 
diets of different pre-agricultural populations existed, which provide insight regarding the 
Western Diet, as it relates to development of chronic, metabolic disorders.  
The World Health Organization recommends humans intake 10% of our daily energy 
from sugar (The World Health Organization, 2003); however in 2004 Canadians 
consumed, on average, 21% of calories from sugar (Health Canada, 2005). Although it is 
difficult to determine sugar consumption of early humans, it is estimated to have 
accounted for a much smaller percentage of total energy (Cordain et al., 2000b; Brand-
Miller et al., 2002). Furthermore, there has been a marked shift in fatty acid consumption 
between pre- and post-industrial humans (Cordain et al., 2000b). Additional changes in 
fatty acid composition between pre- and post-agricultural populations stem from meat 
sources. Wild mammals exhibit seasonal changes in fat storage, where excess energy is 
converted to triacylglycerides and mainly stored in adipocytes as saturated fatty acids 
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(SFAs) (Mercer, 1998). Fatty acids found in muscle and other tissues however are mainly 
polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) (Rule et 
al., 2002) thus hunters eating skeletal muscle as meat would have had a diet rich in 
PUFAs and MUFAs for the majority of the year (Cordain and Watkins, 2002). In 
contrast, post-agricultural populations consume higher SFA content from meat for two 
main reasons: animal husbandry and technological advancements in corn harvesting. 
First, animal husbandry has allowed for slaughter at peak fatty acid storage year round 
compared to the seasonal peak fatty acid found in wild mammals (Whitaker, 1975). 
Second, animals are now kept in feed lots and fed grain (mostly corn) and exhibit 
“marbled meat”, i.e. intramuscular adipose deposits resulting from excess triacylglycerols 
accumulation (Whitaker, 1975). The triacylglycerol in these deposits is comprised largely 
of SFA (Cordain et al., 2005). Wild meat does not exhibit this “marbling” (Cordain and 
Watkins, 2002).   
On an evolutionary time-scale, 5,000 to 10,000 years is a relatively short period in which 
to undergo such drastic environmental changes. Environmental pressures can either 
positively or negatively select for genetic traits, and a changing environment may be 
discordant with widely favorable genetic traits from a previous environmental pressure 
(Gould, 2002; Caldararo, 2003). The current human genome has been primed for the diet 
of our ancestors and is discordant to the present day “Western Diet” (Eaton et al., 1988; 
Caldararo, 2003). Increased sugar consumption and a shift in the fatty acid composition 
from mainly PUFAs and MUFAs to SFAs are staples of the Western Diet (Cordain et al., 
2005).  
An emerging body of evidence suggests that high fat, high sugar diets are closely linked 
to metabolic disorders (Hu et al., 2001; Cordain et al., 2005; Kuo et al., 2008; Lottenberg 
et al., 2012). High sugar diets increase blood glucose levels, leading to increased insulin 
secretion (Ludwig, 2002). Over time cells become insulin resistant, even compared to 
isocaloric diets with low sugar (Miller, 1994). Promotion of insulin resistance by a high 
sugar diet has adverse metabolic effects and is an early indicator for type II diabetes and 
cardiovascular disease (Ludwig, 2002; Cordain et al., 2003). Additionally, following a 16 
week high-fat high sugar diet, mice have shown decreased skeletal muscle citrate 
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synthase activity (a marker of functional mitochondrial abundance) and decreased 
oxidative fiber expression in conjunction with insulin resistance (Bonnard et al., 2008), 
indicating an association between mitochondrial dysfunction, diet and development of 
metabolic disorders.  
 
1.5.2  Mechanisms of sugar and saturated fats’ negative impacts 
and increased risk of metabolic disease 
 
Metabolic dysfunction with respect to FAs occurs due to insulin resistance, increased 
plasma cholesterol and adiposity (Hokanson and Austin, 1996; Turco et al., 2014). 
Although the total amount of FAs consumed can contribute to metabolic perturbations, 
recent studies show that the FA quality (PUFA, MUFA or SFA) can also influence 
disease development (Hokanson and Austin, 1996; Turco et al., 2014) likely because of 
their different biochemical properties.  
Saturated fatty acids are classified as such because each carbon of the acyl chain is 
saturated with hydrogen molecules, and there are no double bonded carbons. Mono and 
polyunsaturated fatty acids are those with one or multiple double bonds, respectively. 
These double bonds create bends in the hydrocarbon chain and therefore unsaturated fats 
have less dense overall structures. Dietary intake of SFAs, particularly palmitate, the 
most abundant dietary SFA, increases total plasma cholesterol and decreases low density 
lipoprotein (LDL) receptor expression, thereby indirectly increasing plasma LDL levels 
(Chappell et al., 1993; Rioux and Legrand, 2007). Plasma cholesterol, specifically in the 
form of LDL or VLDL are important risk factors in metabolic syndrome, CVD and type 
II diabetes (Hokanson and Austin, 1996). Intracerebroventricular injections of palmitate 
simulate insulin resistance in the brain (Posey et al., 2009) and decrease PGC-1α 
expression in skeletal muscle (Coll et al., 2008), providing further support for palmitate’s 
association with development of metabolic disorders. 
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A recent review noted that adolescents in half of the 30 studied countries are ingesting 
more SFAs than recommended by World Health Organization, and failing to reach the 
recommended intake of PUFAs (Harika et al., 2011). PUFAs are important in membrane 
fluidity but can influence lipogenesis by modulation of PPARα, similar to MUFAs 
(Lichtenstein and Ausman, 1994; Hannah, Ou and Luong, 2001; Assy and Nassar, 2009; 
X. Yang et al., 2011). Studies demonstrate that SFA induced insulin resistance is 
associated with impaired glucose transport or phosphorylation (Holland et al., 2011; 
Martins et al., 2012). Skeletal muscle specific studies show reduced IRS (insulin receptor 
substrates)-1 tyrosine phosphorylation (Yu et al., 2002) following SFA infusion. 
Tyrosine phosphorylation of IRS-1 leads to a phosphorylation cascade which results in 
increased glucose uptake. Conversely, dietary intake of MUFAs ameliorate insulin 
resistance in skeletal muscle (Yang et al., 2011). 
 
1.6 Thesis Rationale and Objectives 
 
1.6.1 Rationale 
 
Metabolic disorders are linked to poor in utero environments and can develop 
independent of post-natal diets (Barker, 2004; de Boo and Harding, 2006). A poor in 
utero environment, characterized by decreased oxygen and nutrient transfer across the 
placenta, is associated with LBW and IUGR outcomes (Byberg et al., 2000; Pardi et al., 
2002; Burke et al., 2006). These outcomes are observable phenotypes linked to an 
underlying physiological perturbation: a reprograming event (Neel, 1999; Barker, 2004). 
Fetal reprograming occurs in low oxygen and low nutrient environments, and consists 
primarily of a redirection of blood flow, sparing some organs (brain, heart and 
adrenals)(de Boo and Harding, 2006). Meanwhile, other organs and tissues such as the 
liver, kidneys and skeletal muscle experience a reduction in blood flow (Peleg, Kennedy 
and Hunter, 1998). This in utero environment is proposed to reprogram tissue gene 
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expression leading to the observed predisposition of IUGR offspring to metabolic 
disorders (Barker, 2004; de Boo and Harding, 2006). 
In addition to their associations with a poor in utero environment, increased incidence of 
metabolic disorders such as insulin resistance and type II diabetes have been linked to the 
increased prevalence of a high-fat, high-sugar WD (Cordain et al., 2005). Specifically, 
SFAs, and processed sugars, present in higher proportion in the WD compared to other 
diets (Cordain et al., 2000a), have been identified as key components in the development 
of metabolic disorders (Holland et al., 2011).  
Underlying in utero reprogrammed changes in IUGR mitochondrial function and how 
these changes may interact with an adverse postnatal environment, such as a WD are 
currently ill-defined. Skeletal muscle biopsied from insulin resistant individuals have 
reduced rates of oxygen consumption (Gosker et al., 2002; Mogensen et al., 2007). 
Oxygen consumption may be altered due to the changes in fiber type composition 
because of differences in preferred metabolic pathways of the different fiber types. 
Oxidative fibers (type Ia, IIa and IIx) have a high density of mitochondria and capillaries 
and therefore respire at higher rates than their glycolytic (type IIb) counterparts (Lillioja 
et al., 1987; Schiaffino and Reggiani, 2011). IUGR offspring show impaired 
mitochondrial function manifesting as reduced oxygen consumption in skeletal muscle 
attributed to reduced electron transport chain complex I activity, therefore skeletal muscle 
oxygen consumption is proposed as an early predictor for such metabolic diseases.  
I therefore postulate that in utero hypoxia reprograming reduces oxygen consumption, 
and that a WD, or palmitate alone, will aggravate mitochondrial dysfunction whereas 
palmitoleate (a MUFA) will mitigate hypoxia-induced reductions in oxygen 
consumption.  
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1.6.2 Objectives and Hypotheses 
My first objective was to determine the rate of oxygen consumption in LBW fetal guinea 
pig soleus muscle compared to normal birth weight (NBW) animals, ex vivo. I 
hypothesized that hypoxia (through placental insufficiency) will alter muscle oxygen 
consumption during development. I predicted that LBW animals would have reduced 
soleus oxygen consumption. 
My second objective was to determine the effects of growth restriction on oxygen 
consumption rate and skeletal muscle fiber type composition in young adult LBW guinea 
pigs independently and in conjunction with a post-natal WD. I hypothesized that WD 
interacts with IUGR metabolic reprogramming and predicted that LBW/control diet-fed 
animals and NBW/western diet fed animals will exhibit increased glycolytic fiber ratios 
and reduced oxygen consumption while LBW/western diet-fed animals will have even 
further increases in glycolytic fiber ratios compared to NBW/control-diet fed animals as 
well as either treatment independently. I tested these two hypotheses using a whole-
animal model of IUGR leading to a LBW outcome. 
My final objective was to isolate hypoxia-specific effects of IUGR on skeletal muscle 
differentiation, metabolism and mitochondrial function and evaluate the effects of 
saturated fatty acids and monounsaturated fatty acids on oxygen consumption in a cell-
based model system. It would be difficult to achieve this objective in a whole-animal 
model, so I used a skeletal muscle cell culture model where I could control oxygen as 
well as nutrient quantity and quality. It was postulated that hypoxia and fatty acid type  
alter oxidative metabolism through changes in fiber type. Specifically, I predicted that 
hypoxic cultured cells would consume less oxygen than normoxic cultured cells and that 
SFAs will exacerbate this while MUFAs would have a mitigating effect through changes 
in oxidative and glycolytic fibers. 
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2 Materials and Methods 
 
2.1.1 Surgical Induction of Growth Restriction 
 
All animal procedures were approved by the University of Western Ontario Animal Use 
Subcommittee in accordance with the Canadian Council on Animal Care guidelines. 
Pregnant Dunkin-Hartley guinea pigs (Charles River Laboratories, Wilmington, MA, 
USA) were housed with a 12/12 hour light/dark cycle and allowed access to standard 
guinea pig chow (LabDiet diet 5025: 27% protein, 13% fat, 60% carbohydrates) ad 
libitium. Fetal samples were obtained from sows that underwent uterine artery ablations 
(UAA) performed mid-term (approximately day 35 of a 68-day gestation) to induce 
IUGR by a veterinary technician. Following anesthesia (4-5% Isoflurane with 2L/min O2 
for induction, followed by 2.5-3% Isoflurane with 1L/min O2 for maintenance), a 
subcutaneous injection of Robinul (Glycopyrrolate, 0.01mg/kg, Sandoz Can Inc., 
Montreal QC) was administered. To expose the bicornate uterus, a midline incision was 
made below the umbilicus and subsequently the UAA was performed by cauterization of 
50% of uterine artery branches using an Aaron 2250 electrosurgical generator (Bovie 
Medical, Clearwater, FL)(Turner and Trudinger, 2009) 
Guinea pig studies were divided into two experiments, one examined the direct impact of 
the in utero insult and a second focused upon the long-term effects of an adverse in utero 
environment combined with a second insult of a poor Western diet during a post-natal 
growth phase. In the first study, fetal soleus muscle was collected near term 
(approximately gestational day 65 of a 68-day term). These muscles were used for 
respirometry experiments and came from fetuses that were categorized as either control 
(fetuses weighing more than 90 grams) or IUGR (fetuses weighing less than 85 grams; 
Figure 2.1-1). 
In the second study both UAA and sham-operated controls were carried to term and 
allowed to grow for four months, fed either a control or Western diet (see section 2.1.2, 
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below). Animals whose birth weight fell below the 25th percentile of all pups born were 
categorized as LBW and those whose birth weight fell between the 25th and the 75th 
percentile were categorized as normal birth weight (Thompson et al., 2011). In 
accordance with previous data (Kind et al., 2003; Briscoe et al., 2004) and meeting these 
criteria, LBW animals were below 85g at birth and normal birth weight animals were 
above 90g at birth. Four months after birth soleus muscle was collected from these 
animals for respirometry and molecular analysis (further described in section 2.4) 
2.1.2 Post-Natal Life and Feeding 
 
Guinea pigs that carried to term were weaned at 15 days of age and housed in individual 
cages maintained at 20°C ± 2°C, 30-40% relative humidity with a 12-hour light/dark 
cycle. At weaning, offspring were randomly assigned to either a control diet (CD, 3.4 
kcal/g; product number TD: 110240, Harlan Laboratories, Madison WI) or a Western diet 
(WD, 4.2 kcal/g; product number TD: 110239, Harlan Laboratories, Madison WI; Figure 
2.1-1). The control diet was comprised of a high complex carbohydrate content, but low 
fructose and sucrose with the majority of fats being PUFA, and very low SFA content. In 
contrast, the WD has less overall carbohydrate composition, but higher fructose and 
sucrose content, and a larger percentage of SFA (Table 2.2-1). Once weaned, pups were 
then classified into four experimental groups: normal birth weight on a control diet 
(NBW/CD), low birth weight on a control diet (LBW/CD), normal birth weight on a 
Western diet (NBW/WD), and low birth weight on a Western diet (LBW/WD). Animals 
were maintained on these diets and sacrificed at ~150 days, corresponding to young 
adulthood (Gomez-Pinilla et al., 2007). 
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Figure 2.1-1 Overview of Guinea Pig animal model for uterine artery ablation and 
post-natal diet. Uterine artery ablations (UAA) or sham control surgeries were 
performed on pregnant sows. Pups born from UAA sows weighing less than 85g were 
considered LBW, weaned and then given either a control or Western diet. Pups born from 
sham surgeries weighing more than 90g were considered NBW, weaned and given either 
a control or Western diet. Animals were sacrificed and soleus muscle was collected at 
day 150. 
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Table 1.6-1 Guinea Pig Diet Comparison (percent calories) 
Nutritional information 
Control Diet Western Diet 
Calories 
3.4 Kcal/g 4.2 Kcal/g 
Protein 
22% 21% 
Carbohydrates 
60% 33% 
Sucrose 
11% 22% 
Fructose 
- 7.6% 
Fat 
18% 46% 
Saturated fatty acids 
2.7% 32.2% 
Monounsaturated fatty acids 
4.32% 11.96% 
Polyunsaturated fatty acids 
10.98% 1.84% 
 
2.1.3 Tissue Collection 
 
In the first study, which compared control and IUGR fetuses, pregnant sows near term 
(gestational day 65) were sacrificed by CO2 asphyxiation following an overnight fast 
(Greulich et al., 2011) and fetuses were removed. In the second study of post-natal diet 
effects on LBW and NBW offspring, animals born to both UAA and sham operated sows 
were sacrificed at postnatal day 150, corresponding to young adulthood (Briscoe et al., 
2004), by CO2 asphyxiation following an overnight fast (Greulich et al., 2011).  From 
every animal (fetus and offspring) one soleus muscle was removed and used immediately 
for respirometry (described in section 2.2, below). and the contralateral muscle, flash 
frozen in liquid nitrogen for CS activity. In addition, for the 150-day old NBW and LBW 
animals only, soleus muscle was also collected and frozen for fiber typing mRNA 
determinations and ETC immunoblot analysis (described in sections 2.3 and 2.4 below).  
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2.2 Soleus Respirometry 
 
The soleus muscle dissected from control and IUGR fetuses, as well as 150 day old NBW 
and LBW animals was stored on ice in BIOPS buffer (50mM K+-MES, 20mM taurine, 
0.5mM dithiothreitol, 6.56mM MgCl2, 5.77mM ATP, 15mM phosphocreatine, 20mM 
imidazole pH 7.1 adjusted with 5N KOH at 0°C, containing a Ca-EGTA buffer (2.77mM 
CaK2EGTA + 7.2mM K2EGTA; 0.1μM free calcium) until permeabilized. The soleus 
muscle tissue was kept ice-cold and teased apart using sharp forceps to isolate muscle 
fiber bundles 3-4mm long and 1mm in diameter, exposing a fairly large surface area. The 
fibers were incubated in BIOPS supplemented with saponin (50μg/ml) for 30 minutes 
(optimal for skeletal muscle; Kuznetsov et al., 2008), permeabilizing the cells by binding 
to cholesterol in the sarcolemma, thereby allowing access of oxidative substrates and 
ADP to the mitochondria without further disrupting the tissue. In contrast to sarcolemma, 
mitochondrial membranes contain little cholesterol, so are relatively unaffected by 
saponin incubation. Following permeabilization, tissue was washed 3 times in MiR05 
buffer (110mM sucrose, 60mM K-lactobionate, 0.5mM EGTA, 3mM MgCl2, 20mM 
taurine, 10mM KH2PO4, 20mM HEPES adjusted to pH 7.1 with KOH at 37°C; and 
1g/litre BSA fatty acid free) for 2 minutes. 
 Rates of oxygen consumption, with oxidative substrates and ADP (state 3) and following 
ATP synthesis (state 4), were determined using the Oxygraph-2k (Oroboros), with Clark-
type O2 electrodes in airtight 2mL chambers at 37°C. Glutamate (10mM final 
concentration) and pyruvate (5mM) were injected into the chamber along with malate 
(2mM) as substrates for respiration through ETC complex I. In separate incubations 
succinate (10mM) was solely used as an ETC complex II substrate, with rotenone 
(0.5μM) added to inhibit ETC complex I arising from endogenous substrate metabolism. 
Once respiration rate with only substrates stabilized, ADP (2mM) was added, stimulating 
state 3 (maximal physiological) respiration. After recording stable state 3 rates 
oligomycin (5mM) was injected into the Oxygraph chamber to inhibit complex V 
activity, allowing estimation of state 4 respiration.  
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2.3 Citrate Synthase Activity 
 
Soleus muscle from control and IUGR fetuses, as well as 150 day old NBW and LBW 
animals was dissected and frozen in liquid N2 and tissue stored at -80°C. Samples were 
then homogenized in radioimmunoprecipitation assay buffer (RIPA; 50mM Tris-HCl, 
NP-40 1%, Na-deoxycholate 0.25%, 1mM EDTA, 150mM NaCl, 50mM NAF, 1mM 
NaV, 25mM β-glycerophosphate, pH 7.4) with protease and phosphatase inhibitors. One 
aliquot was used for western blots (see section 2.4) and another frozen at -80°C until it 
was used for citrate synthase (CS) activity. Thawed homogenate was sonicated then 
centrifuged at 2000g for 5 min at 4°C. 
The CS reaction was followed in 96-well plates in triplicate by measuring absorbance at 
412nm using a spectrophotometer. Wells were loaded with 220μl reaction buffer 
(consisting of 25mM HEPES, 0.1% Triton X-100 and 2mM EDTA) 30μl of 0.15mM 
5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB), 30μl of 0.15mM acetyl CoA and 3μl of 
homogenate (Eigentler, Draxl and Wiethüchter, 2012). The reaction was started by 
adding 30μl of 0.33mM oxaloacetate. Blank rates were also recorded in a well which 
contained homogenate but to which buffer was added instead of oxaloacetate. 
Absorbance was recorded for 5 minutes at 37°C and maximal activity was calculated 
from the slope of absorbance vs. time using a minimum of 7 consecutive absorbance 
readings during the 5 minutes (readings taken every 1 second), after subtracting rates 
from blank wells. Data were expressed as enzymatic activity per mg soleus muscle 
protein. 
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2.4 Molecular Analysis 
 
Frozen soleus muscle from 150-day old animals NBW and LBW animals only were used 
for the following mRNA and immunoblotting procedures. 
 
2.4.1 Rt-qPCR for Myosin Heavy Chain isoform expression  
Guinea pig soleus was powdered using a mortar and pestle in liquid N2, homogenized 
using a disposable homogenization pestle and stored in Trizol reagent (Invitrogen, 
Burlington ON) at -80°C until use. Total RNA was extracted using the Trizol procedure; 
samples were thawed and incubated at room temperature for 5 minutes, 200µL of 
chloroform was added to the solution and shaken vigorously by hand for 15 seconds. 
Samples were left at room temperature for 2 minutes and then centrifuged for 15 minutes 
at 12,000g at 4°C separating the aqueous phase (containing RNA), an interphase and a 
phenol-chloroform phase. The aqueous layer was transferred to a new RNAase-free tube 
and 500µL of isopropanol was added to the solution which was incubated at room 
temperature for 10 minutes. Following incubation, samples were centrifuged for 10 
minutes at 12,000g at 4°C, precipitating RNA into a pellet. Samples were then washed 
twice with 100µl of 75% ethanol, centrifuging at 7,500g for 5 minutes after each wash. 
Samples were stored at -80°C until use. 
The yield of isolated RNA was determined using a NanoDrop 2000 spectrophotometer 
(Thermo-Scientific) and quality was measured using the A260/A280 ratio (≥1.8). Isolated 
RNA (4μg) was incubated with deoxyribonuclease (Invitrogen) to remove any 
contaminating DNA and a recombinant ribonuclease inhibitor (Invitrogen) at 37°C for 30 
minutes. Samples were then incubated at 37°C for two hours with murine leukemia virus 
reverse transcriptase (Invitrogen) to produce cDNA with the use of random primers. 
Real-time quantitative PCR (qPCR) was performed using SoFast EvaGreen Supermix 
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(Invitrogen) and the BioRad CFX384 Real-Time PCR Detection System at denature 
temperature of 95°C, annealing temperature of 59.5°C and elongation temperature of 
72°C for 40 cycles. A total volume of 8μl in each well contained 3μl of cDNA, 0.08μl 
primer mix, 4µl SYBR Green and the remaining volume was filled with autoclaved 
water. Primer sets directed against guinea pig specific myosin heavy chain genes were 
generated using the NCBI Primer-BLAST tool based on predicted Cavia porcellus 
sequences (Table 2.4-1). The data from qPCR was analyzed using the 2-ΔΔCt method 
(Livak and Schmittgen, 2001) using β-actin as the internal control gene. 
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Table 2.4-1 Guinea Pig Myosin Heavy Chain primer pairs. 
Primers NCBI accession # Strand Sequence (5’    3’) 
Myh7 (type 
1A) 
XM_003474485.2 
Forward 
Reverse 
CAGGAGTGCAGGAATGCTGA 
GTTATGCAGGTGCCAGGGAT 
Myh4 (type 
2B) 
XM_005002092.1 
Forward 
Reverse 
GTACACCTAACCTGCAGCCA 
GTTGTCGTTCCTCACGGTCT 
Myh2 (type 
2A) 
XM_005002092.1 
Forward 
Reverse 
CCTTTGAAGAGCGACACTGG 
TCAGCATGAACTGGTAGGCG 
Myh1 (type 
2x) 
XM_003466219.1 
Forward 
Reverse 
TCATCCCTACAGGCAAGGTC 
AGAGGCCCGAGTAGGTGTAG 
 
2.4.2 Immunoblotting of Electron Transport Chain Complex 
Subunits  
Protein concentrations of homogenized soleus (described in section 2.3) were determined 
using BCA protein concentration kits (Pierce Biotechnology, Rockford IL). Samples 
were then prepared using NuPAGE LDS sample buffer (Invitrogen) and NuPAGE 
Sample Reducing Agent (Invitrogen). Approximately 15μl of soleus extracts (20µg of 
protein) were separated on NuPAGE 4-12% Bis-Tris gels and subsequently washed in 
TBST (137mM NaCl, 2.7mM KCl, 19mM Tris base, 0.1% Tween 20) 3 times for 10 
minutes. Membranes were then incubated in TBST supplemented with the MitoProfile 
Total OXPHOS Rodent Antibody Cocktail (Complex I subunit NADH dehydrogenase 
[ubiquinone] 1 beta subcomplex 8, NDUFB8; Complex II Iron-sulfur protein subunit; 
Complex III Core protein 2; Complex IV subunit I; Complex V alpha subunit) at a 
1:1000 dilution (ab110413, host: mouse; Mitosciences, Eugene, OR). Membranes were 
then washed three times with TBST for 15 minutes and then incubated for one hour in 
TBST supplemented with a donkey anti-mouse horseradish peroxidase secondary 
antibody. To probe for the housekeeping protein (voltage dependent anion-selective 
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channel protein 1, VDAC1), membranes were prepared in a similar manner as described 
above with primary antibody at a 1:5000 dilution (ab14734, host: mouse; Invitrogen). 
Immunoreactive bands were detected with enhanced chemiluminescence and imaged 
with a VersaDoc Imaging System (Bio-Rad, Mississauga, ON). Densitometry was 
performed with ImageLab Software (Bio-Rad). 
 
2.5 Hypoxic C2C12 Cells and Fatty Acid 
Supplementation 
 
C2C12 mouse myoblast cells were cultured to test the third hypothesis; that hypoxia and 
fatty acid type alter oxidative metabolism. Cells were cultured at 37°C in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin until cells reached 70-80% confluence (~ 48 hours) at 20.9% O2 
(5% CO2 with N2 balance). Once cells reached confluence, growth media was replaced 
with differentiation media (DMEM supplemented with 5% horse serum and 1% 
penicillin/streptomycin) inducing myoblast differentiation. The cells were then allowed to 
differentiate at 37°C at either 1% (to simulate in utero hypoxia) or 5% O2 (to simulate 
typical in utero conditions) for five days of differentiation. Following differentiation, a 
subset of cells was incubated at 20.9% O2 for 48 hours (recovery; Figure 2.2-1). During 
recovery, a further subset of cells was exposed to 0.5mM palmitate (saturated fatty acid; 
16:0), 0.5mM palmitoleate (mono-unsaturated fatty acid; 16:1) 10% fatty acid free BSA 
(vehicle used to conjugate fatty acids) was used as a control for 24 hours (figure 2.2-2). 
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2.5.1 Time points for collection 
 
Untreated whole cells were collected prior to differentiation (day 0; cells cultured in 
growth media at 20.9% O2), after 5 days of differentiation (day 5; cells cultured in 
differentiation media at either 5% O2 or 1% O2) and following 48 hours of recovery (day 
7; cells differentiated at either 5% O2 or 1% O2 for 5 days, then transferred to 20.9% O2 
for 2 days). Cells treated with fatty acids or BSA were collected at days 0, 5 and 
following 24hrs of fatty acid exposure (day 6). 
 
 
Figure 2.5-1 Diagram of cell culture experiments. C2C12 mouse myoblasts were 
cultured at 20.9% oxygen until they reached ~ 80% confluence. Cells were then 
differentiated under either 5% O2 (simulating normal in utero oxygen levels) or 1% O2 
(simulating oxygen under IUGR conditions) for 5 days. Following differentiation, cells 
were placed into recovery conditions for 48 hours (20.9% O2). 
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2.5.2 Rate of Oxygen Consumption in Cell Culture 
 
Whole cells were collected for respirometry in a standard buffer (130mM NaCl, 5mM 
KCl, 0.5mM MgCl2, 25mM HEPES; pH 7.4) and supplemented with 10mM glucose as 
metabolic substrate. Rates of O2 consumption were measured using the Oroboros 
Oxygraph-2k. These rates were calculated at 50μM O2 (equivalent to equilibration at 5% 
O2) and 10μM O2 (1% O2) and expressed per 106 viable cells. Cell counts and viability 
were determined using a heamocytometer and trypan blue, as previously described (Yun 
et al., 2005). 
  
Figure 2.5-2 Diagram of hypoxic cells treated with fatty acids. C2C12 mouse myoblast 
were cultured at 20.9% oxygen until they reached ~ 80% confluence. Cells were then 
differentiated under 5% O2 (simulating normal in utero oxygen levels) or 1% O2 
(simulating oxygen under IUGR conditions) for 5 days. Following differentiation, 0.5mM 
palmitate (saturated fatty acid; 16:0), 0.5mM palmitoleate (mono-unsaturated fatty acid; 
16:1) or 0.5mM 20% BSA (vehicle used to conjugate fatty acids) was added to the 
differentiation media for 24 hours at 20.9% O2. 
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2.5.3 Extraction and Quantification of Mitochondrial DNA from 
Cultured Cells 
 
Mitochondrial DNA was extracted to determine if any changes in oxygen consumption 
rates in hypoxia were related to mtDNA content. C2C12 Cells were collected in phosphate 
buffer saline solution (PBS) and pelleted at 10,000g for 5 minutes. The PBS supernatant 
was removed with a pipette and the pellet was stored at -80°C. The pellets were re-
suspended in 200µL TNES (50mM Tris-HCl pH 8.0, 100mM EDTA pH 8.0, 100mM 
NaCl, 500mg/mL Proteinase K, 1% SDS) and heated at 55°C for 4 hours. Each sample 
was supplemented with 500µL phenol/chloroform/isoamyl alcohol (25:24:1) and 
repeatedly inverted by hand for 1 minute. Samples were then centrifuged at 10,000g for 3 
minutes separating the sample into an upper aqueous phase, an interphase containing 
DNA, and a lower phenol/chloroform phase. The aqueous phase and interphase were 
transferred to a fresh tube. Next, DNA was extracted with chloroform following the same 
steps as with the phenol/chloroform/isoamyl alcohol extraction, again collecting the 
aqueous phase and interphase. 50µL of 3M C2H3NaO2 and 1mL of 100% ethanol were 
added to the samples which were then inverted for 30 seconds, precipitating the DNA. 
The supernatant was removed and 500µL of 70% ethanol was added. Samples were 
inverted for 30 seconds and centrifuged at 12,000g for 10 minutes, pelleting the DNA. 
The ethanol was removed and the pellet was re-suspended in 200µL H2O and stored at -
80°C until use for qPCR. 
The yield of isolated DNA was determined using the NanoDrop 2000 spectrophotometer 
(Thermo-Scientific) and quality was measured using the A260/A280 ratio (≥1.8). Real-
time quantitative PCR was performed as described in section 2.4 Primer sets directed 
against mouse specific mitochondrial D-loop genes were generated using the NCBI 
Primer-BLAST tool based on Mus musculus sequences (Table 2.2.1). The data from 
qPCR was analyzed using the 2-∆∆Ct method(Livak and Schmittgen, 2001) using β-actin 
as the internal control gene. 
 
33 
 
Table 2.5-1 Mitochondrial DNA mouse primer pairs. 
Primers NCBI accession # Strand Sequence (5’    3’) 
mt D-loop KM114847.1 
Forward 
Reverse 
TGCGTTATCGCCCATACGTT 
GCGTCTAGACTGTGTGCTGT 
 
2.6 Statistics 
 
GraphPad Prism 5 was used for all statistical analyses. Guinea pig weight and thinness 
data are presented in box whisker plots, representing the median, 25th and 75th quartiles 
and min/max values. An unpaired Student’s t-test was used to compare the means of fetal 
respiration of control and IUGR animals and an f-test was used to ensure equal variance.  
Means compared between NBW/CD, NBW/WD, LBW/CD and LBW/WD for soleus 
respiration, mitoprofile protein expression, myosin heavy chain mRNA expression and 
citrate synthase activity were analysed using a two-way ANOVA with a Bonferroni post-
hoc test. A two-way ANOVA with Bonferroni post-hoc test was used to compare mean 
oxygen consumption of C2C12 mouse myoblast cells cultured under 5% or 1% oxygen 
and following reoxygenation (day 5 and day 7). Mean oxygen consumption of C2C12 
mouse myoblast cultured under 5% and 1% oxygen and whose media was supplemented 
with BSA, palmitate or palmitoleate was compared using a two-way ANOVA with a 
Bonferroni post-hoc test.  A p value of less than 0.05 was considered significant. The 
Bartlett’s test was used to measure equal variance for all grouped data, MHC2, MHC4, 
MHC1 and MHC7 data did not have equal variance.  
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3 Results 
 
3.1 Growth Restriction Induced Alterations in Fetal 
Soleus Muscle Respiration 
 
Fetal weights were recorded at collection which occurred at approximately gestational 
day 65 (term 68 days). Fetuses arising from UAA surgeries and weighing less than 85 
grams were categorized as IUGR and those born from sham surgeries weighing more 
than 90 grams were categorized as controls. IUGR fetuses had a 28% lower birth weight 
(Figure 3.3-1; p<0.001). 
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Figure 3.1-1 Fetal body weights at collection. Body weights of fetuses from UAA 
pregnancies weighing less than 85g (IUGR) compared to fetuses born from sham 
surgeries weighing more than 90g (control). The boxes represent the 25th and 75th 
percentiles, the bars indicate min/max values and the line indicated the median (Control 
n=9, IUGR n=6; df=13). *** indicates significance of p<0.001 between groups as 
determined by an unpaired Student’s t-test. 
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Fetal soleus was collected and permeabilized using saponin in order to measure 
respiration states. IUGR soleus had 24% lower state 3 respiration with pyruvate as 
substrate (p<0.05), but there were no significant differences with succinate or glutamate 
(Figure 3.1-2). There were no significant changes in state 4 respiration between IUGR 
and control animals. 
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Figure 3.1-2 State 3 (A, C, E) and State 4 (B, D, F) respiration of fetal Guinea Pig 
soleus muscle with either (A, B) pyruvate, (C, D) glutamate or (E, F) succinate as 
oxidative substrate. Rate of oxygen consumption was measured by closed cell 
respirometry using the Oxygraph-2K at 37°C in MiR05 buffer. Tissue was permeabilized 
with 0.9 mM saponin in BIOPS for 20 minutes followed by three 2 minute washes in 
MiR05. State 3 data displays rate of oxygen consumption subsequent to the addition of (A) 
10mM pyruvate and malate 5mM ADP, (B) 30mM glutamate and malate 5mM ADP or (C) 
0.5µM rotenone, 30mM succinate and ADP. State 4 data displays rate of oxygen 
consumption following complex V inhibition by 2.5µM oligomycin. Data presented as 
means ± SEM, p<0.05 between IUGR and Control state 3 reported from an unpaired 
Student’s t-test (Control n=9, IUGR n=6; df=13). 
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3.2 Low Birth Weight and Western Diet Effects on 
Soleus Muscle Respiration 
 
3.2.1 Birth Weights and Thinness 
 
Animals at 150 days old were used for soleus respirometry and molecular analysis. 
Animals resulting from the UAA surgeries and weighing less than 85 grams at birth were 
considered Low Birth Weight animals. Animals resulting from sham controls weighing 
more than 90 grams were categorized as Normal Birth Weight animals. Female offspring 
of UAA mothers display a 31% lower birth weight compared to sham control animals 
(Figure 3.2-1A; p<0.001), and male offspring of ablated mothers display a 28% lower 
birth weight compared to controls (Figure 3.2-1B; p<0.001). To further characterize the 
LBW phenotype and its association with the pathophysiology of IUGR, I calculated a 
measure of thinness (body mass/crown-rump length) and found that LBW animals were 
25% thinner (Figure 3.2-2; p<0.001).  
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Figure 3.2-1 Birth weights of animals used for respirometry and molecular analyses. 
Birth weights of animals born from ablation pregnancies weighing less than 85g (LBW) 
compared to animals born form sham surgeries weighing more than 90g (NBW). The 
boxes represent the 25th and 75th percentiles, the bars indicate min/max values and the 
line indicated the median. *** indicates significance of p<0.001 between groups as 
determined by an unpaired Student’s t-test (NBW females n=8, LBW females n=7, NBW 
males n=8, LBW males n=5; df-A=13, df-B=11).  
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Figure 3.2-2 Birth weight to birth length ratio of 150-day old guinea pigs. Birth 
weight/birth length ratio at birth for animals used in 150-days old studies. Animals born 
from sham surgeries weighing more than 90g are considered NBW and those born from 
ablation pregnancies weighing less than 85g are considered LBW. The boxes represent 
the 25th and 75th percentiles, the bars indicate min/max values and the line indicated the 
median. *** indicates significance of p<0.001 between groups as determined by an 
unpaired Student’s t-test (NBW n=14, LBW n=12; df=24). 
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3.2.2 Soleus Muscle Oxygen Consumption of Young Adult Guinea 
Pigs 
 
Soleus muscle from young adult animals was collected at approximately 150 days of age 
and prepared for respiration in the same way as the fetal muscle. Two-way ANOVA 
indicated strong interaction effects for state 3 respiration with pyruvate and glutamate, 
indicating that the effect of birth weight on respiration depended on post-natal diet. 
(p<0.001 for both; Figure 3.2-3). State 3 respiration was over 2-fold higher in all 
NBW/CD, males and females combined compared to treatment groups (NBW/WD, 
LBW/CD and LBW/WD) with pyruvate as a metabolic substrate (p<0.001; Figure 3.2-3). 
Similarly, there was a reduction in state 3 respiration of over 45% in all treatment groups 
with glutamate (p<0.001; Figure 3.2-3) when compared to NBW/CD animals. There was 
no significant effect of treatment on state 3 respiration with succinate as substrate. 
Interestingly, LBW/WD group did not suffer any additional reductions in oxygen 
consumption when compared to NBW/WD and LBW/CD animals.  
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Figure 3.2-3 State 3 (A,C, E) and State 4 (B, D, E) respiration of permeabilized soleus from 
150-day old Guinea Pig with (A, B) pyruvate, (C, D) glutamate and (D, E) succinate as 
oxidative substrate. Rate of oxygen consumption was measured by closed cell respirometry 
using the Oxygraph-2K at 37°C in MiR05 buffer. Tissue was permeabilized with 0.9mM saponin 
in BIOPS for 20 minutes followed by three 2 minute washes in MiR05. State 3 data displays rate 
of oxygen consumption subsequent to the addition of (A) 10mM pyruvate and 5mM ADP, (C) 
30mM glutamate and 5mM ADP or (E) 0.5µM rotenone, 30mM succinate and ADP. State 4 data 
displays rate of oxygen consumption following ATPase inhibition by 2.5µM oligomycin. Data 
presented as means ± SEM (NBW/CD n=9, NBW/DW n=8, LBW/CD n=6, LBW/WD n=6; 
df=28). Connecting lines indicate significance between those groups as determined by a 2-way 
ANOVA and Bonferroni post-test (**p<0.01; ***p<0.001). 
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3.2.3 ETC Protein Expression and Citrate Synthase Activity 
 
Relative protein expression of subunits from ETC complexes were analyzed by western 
immunoblotting. Nuclear subunits NDUFB8, SDH8, UQCRC3 and ATP5A from 
Complexes I, II, III and V respectively as well as mitochondrially encoded subunit 
MTCO1 of complex IV were targeted using the rodent MitoProfile cocktail antibody. 
Complexes II, IV and V did not change across groups (Figure 3.2-4). Protein expression 
of complex III were decreased in LBW animals by 49% and this effect did not depend on 
post-natal diet (p<0.001; Figure 3.3-4). Two-way ANOVA indicated an interaction effect 
on the expression of Complex I (p<0.05). NBW/WD, LBW/CD and LBW/WD having 
decreased protein expression by 42%, 43% and 39%, respectively compared to NBW/CD 
animals. 
Citrate synthase activity, commonly used to measure functional mitochondrial content, 
was measured by a spectrophotometric assay. No significant differences were found 
between treatment groups when compared to NBW/CD animals, indicating similar 
mitochondrial content in the soleus muscle of 150-day old offspring across treatments; 
however, the interaction effect neared significance (Figure 3.2-5; p=0.051). 
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Figure 3.2-4 Relative protein expression of subunits of electron transport chain 
complex I subunit NDUFB8 (A), complex II subunit SDH8(B), complex III subunit 
UQCRC2 (C), complex IV subunit MTCO1 (D), complex V subunit ATP5A (E) in 
NBW or LBW 150-day old Guinea Pigs fed either a Control or Western Diet. Protein 
levels from ETC complexes 1-5 were measured using Western blot analysis, normalized 
to VDAC1, and outer mitochondrial membrane protein as a loading control. 
Representative blots displayed on the lower right panel. Data presented as means ± SEM, 
2-way ANOVA and Bonferroni post-test determined significance (*p<0.05; ***p<0.001; 
n=5 for each experimental group; df=19). 
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Figure 3.2-5 Citrate synthase activity in the 4-month-old Guinea Pig Soleus. Soleus 
muscle from guinea pigs or normal birth weight (NBW) or low birth weight (LBW) fed a 
control diet (CD) or western diet (WD) at 4 months of age measured using citrate 
synthase activity assay (NBW/CD n=8, NBW/WD n=6, LBW/CD n=4, LBW/WD n=3, 
df=23)). Data presented as means ± SEM compared by a two-way ANOVA with 
Bonferroni post-hoc test. 
 
3.2.4 Fiber Type Compositions 
 
Soleus myosin heavy chain isoform mRNA expression was determined using qRT-PCR. 
Relative mRNA expression of MHC7 (type Ia; slow oxidative fiber) shows an interaction 
effect (p<0.05), with the LBW/WD diet animals having increased expression relative to 
other groups (Figure 3.2-6 A). Expression of MHC2 (type IIa; fast oxidative) also has a 
strong interaction effect (p<0.001), a birth weight effect (p<0.01) and a diet effect 
(p<0.01); expression being high in LBW/WD animals and very low in LBW/CD as well 
as NBW/WD animals (Figure 3.2-6B).  MHC1 (type IIx; fast oxidative) expression is 
significantly higher in LBW animals (p<0.001) however there was no diet effect (Figure 
3.2-6C) and similarly, LBW animals had higher MHC4 (type IIB; glycolytic fibers) 
expression (p<0.05) without diet effect (Figure 3.2-6D).  
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Figure 3.2-6 Relative mRNA expression of myosin heavy chain genes (MHC) in 
NBW or LBW 4 month old Guinea Pigs fed a Control or Western Diet 
(normalized to βactin). Fast oxidative fibers, types 2A and 2X, express MHC2 (A) 
and MHC1(C) respectively, fast glycolytic fibers, type 2B, express MHC4 (B), and 
slow oxidative fibers, type 1A, express MHC7 (B),  (NBW/CD n=7, NBW/WD n=6, 
LBW/CD n=5, LBW/WD n=5, df=22). Data presented as means ± SEM (significance 
determined by a two-way ANOVA with Bonferroni post-hoc test,*p<0.05; ***p<0.001). 
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3.3 Hypoxia and Fatty Acid Induced Alterations in 
Mitochondrial Function in C2C12 Cells 
 
3.3.1 Hypoxia reduced oxygen consumption which persisted after 
normoxic recovery 
 
Rates of oxygen consumption were measured using the Oxygraph-2k, within the airtight 
chamber at 50µM O2 (5% O2). Five days of differentiation under 1% oxygen decreased 
respiration rates by 67% when compared to cells cultured under 5% oxygen (p<0.001; 
figure 3.3-1A). Depressed rates of oxygen consumption were not ameliorated after two 
days of normoxic recovery (p<0.001; 3.3-1A).  Similar results were seen when oxygen 
consumption was measured with 10µM O2 within the chamber (p<0.001; figure 3.3-1B), 
and again recovery failed to alleviate the reduction in respiration rate (p<0.001; figure 3-
6B). 
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Figure 3.3-1 Rate of oxygen consumption in C2C12 cells cultured under hypoxia 
using the Oxygraph-2k. Respiration rates measured at (A) 50µM (PO2 38mmHg) 
oxygen in the chamber after 5 days of differentiation and after 48 hours recovery (i.e. 
Day 7) and at (B) 10µM (PO2 7.6mmHg)oxygen in the chamber after 5 days and after 2 
days recovery (i.e. Day 7). Data are presented as means ± SEM, significance determined 
by a two-way ANOVA with a Bonferroni post-hoc test***p<0.001 (n=6 for cells cultured 
in 5% O2, n=5 for cells cultured in 1% O2; df=21). 
 
 
48 
 
After 5 days of differentiation at either 5% or 1% O2 cells were exposed to different fatty 
acids for 24-hours at 20.9% O2, and the effects on oxygen consumption were measured. 
Exposure to 0.5mM saturated fatty acid (palmitate, C16:0) during recovery reduced the 
rate of oxygen consumption by 47% in 5% O2 cultured cells when compared to BSA 
controls (p<0.05) at 50µM O2 within the chamber. By contrast palmitate had no 
significant effect on cells differentiated at 1% (Figure 3.3-2A). Addition of 0.5mM 
monounsaturated fatty acid (palmitoleate; C16:1) had no effect on oxygen consumption 
of either 5% or 1% cultured cells. Similar results were observed with 10µM O2 within the 
chamber; oxygen consumption was reduced by 60% with the addition of palmitate, on 
5% cultured cells only (Figure 3.3-2B). 
 
 
Figure 3.3-2 Rates of oxygen consumption of cells cultured in 5% and 1% O2 after 24 
hours 0.5mM fatty acid exposure (SFA palmitate C16:0, UFA palmitoleate C16:1 or 
BSA control) at 20.9% O2. Rates were measured with 50µM (PO2 38mmHg; A) and 
10uM (PO2 7.6mmHg; B) within the Oxygraph chamber. Measurements taken using the 
Oxygraph-2k with Clark-type electrodes at 37°C in a 10µM glucose solution in standard 
buffer. Data analyzed using a two-way ANOVA with a Bonferroni post-test. Data are 
presented as means ± SEM groups with different letters are significant at the 95% level (n= 
6 for all cells cultured at 5% O2, n=5 for all cells cultured at 1% O2; df=32). 
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3.3.2 Mitochondrial DNA Was Not Altered by Hypoxia 
 
Mitochondrial DNA was extracted from C2C12 cells at days 2 and 5 of differentiation and 
after recovery (day 7). Using primers specific to the mitochondrial DNA D-Loop 
sequence, quantitative PCR was used to determine mtDNA content. Relative to β-actin 
mRNA expression, there was no significant difference in mtDNA content at any of the 
time points measured between the hypoxic and normoxic cultured cells (Figure 3.3-2) 
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Figure 3.3-3 Mitochondrial DNA unaltered after 2 and 5 days of differentiation or 
after recovery in hypoxic cultured cells. Mitochondrial DNA was extracted using 
liquid-liquid phase separation and subsequently amplified using qRT-PCR and 
normalized to β-actin mRNA expression. Data were analyzed using a two-way ANOVA 
and a Bonferroni post-test (n=6 for all groups; df=35). Data presented at means ± SEM 
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4 Discussion 
 
4.1 IUGR is Associated with Altered Soleus Oxygen 
Consumption 
 
The metabolic alterations in peripheral tissue, such as skeletal muscle, resulting from low 
oxygen and nutrient supply to the fetus are thought to underly the relationship between 
IUGR and later-onset metabolic disorders (Arbeille et al., 1995; Pardi et al., 2002; de 
Boo and Harding, 2006). In this study I present data that support the contention that fetal 
soleus muscle, an oxidative muscle, is negatively altered following uterine artery 
ablation. My data suggests that growth restriction following UAA leads to immediate 
disruption of mitochondrial metabolism in the soleus muscle, which is indicative of an in 
utero reprogramming event. While there is a significant reduction in pyruvate-fueled state 
3 respiration in fetal soleus (figure 3.1-2) a reduction in glutamate oxidation (figure 3.1-
2) which only becomes evident at 4 months of age (figure 3.2-3). Before glutamate can 
be metabolized in the TCA cycle and enter OXPHOS as NADH it must be converted to 
α-ketoglutarate by glutamate dehydrogenase (GDH). An adaptive response of low 
glutamate conversion to α-ketoglutarate in IUGR pregnancies may account for this 
observation as glutamate is present in larger quantities in circulation of IUGR 
pregnancies, however; GDH expression is significantly lower in IUGR placentae and 
liver (Jozwik et al., 2009). I speculate GDH expression may be altered in the soleus 
however further work would be needed to better understand this relationship. 
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4.2 IUGR and Diet Independently Reduce Soleus 
Oxygen Consumption 
 
Rates of mitochondrial oxygen consumption for 4-month-old animals were measured in 
permeabilized soleus muscle as it is comprised of mainly oxidative fiber types and thus 
produces most of its ATP by the aerobic process of OXPHOS. Both LBW and WD 
treatments reduced maximal (state 3) oxygen consumption when pyruvate and glutamate 
were used as metabolic substrates (Figure 3.3-3) but these effects were not additive as no 
further reductions in oxygen consumption were noted in the LBW/WD group. 
Additionally, no changes in oxygen consumption across any treatments were noted 
following succinate administration, suggesting a loss of function at complex I, where 
electrons from NADH (downstream product of pyruvate and glutamate) enter the ETC 
but maintained function of complex III (where electrons from succinate enter the ETC). 
Furthermore, I found no differences in citrate synthase activity, suggesting a similar 
number of functional mitochondria among treatment groups. Taken together, these data 
suggest reduced oxygen consumption in IUGR and WD can be attributed to impaired 
complex I activity rather than a reduction in mitochondrial number. This is supported in 
the present study by reduced protein expression of mitochondrial subunit NDUFB8 in all 
treatment groups (Figure 3.2-4A). A recent study of rat heart tissue however saw no 
changes in NDUFB8 expression in IUGR groups (Beauchamp et al., 2015) while still 
noting a decrease in state 3 respiration. This discrepancy may be explained by comparing 
in utero blood flow, while the heart is spared, skeletal muscle exhibits a marked decrease 
in blood flow (Phillips et al., 1994; Hales and Barker, 2001). Reduced NDUFB8 could 
therefore be an example of persistent epigenetic reprogramming target as a consequence 
of a poor in utero environment. Previous studies have determined that complex I proteins 
are in fact the target of epigenetic modification, for example mtDNA protein MT-ND6 is 
differentially methylated in NAFLD (Pirola et al., 2013) and that microRNA miR-663 
alters the expression of complex I protein NDUFAF1 (Carden et al., 2017).    
Other than complex I, complex III protein expression was the only other complex 
affected by my treatments. Where complex I protein expression was reduced by both 
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treatments, complex III protein expression was only reduced in the LBW group (Figure 
3.2-4 C). This reduction in complex III expression does not seem to have a functional 
consequence in terms of oxygen consumption, as LBW animals do not exhibit a further 
decrease in oxygen consumption compared to WD animals (Figure 2.3-3), and there was 
no difference in state 3 rates with succinate as a substrate. Together, these results suggest 
that the reduction of cytochrome c by reduction of coenzyme Q by complex III is not a 
rate limiting step in SM oxidative phosphorylation.  
 
4.3 Soleus Myosin Heavy Chain Expression Altered by 
Birth Weight and Diet 
 
In conjunction with changes in oxygen consumption as a result of LBW expression of 
myosin heavy chain isoforms indicates a change in skeletal muscle fiber types. In the 
Guinea pig, MHC 7 is present in oxidative type 1 fibers, MHC 2 in oxidative type IIa 
fibers, MHC 1 in oxidative type IIx fibers and MHC 4 in glycolytic type IIb fibers 
(Tonge et al., 2010). At the mRNA level, I observed an increase in MHC 4 expression 
which alone would support my hypothesis that a poor in utero environment alters fiber 
type composition but is not consistent with the mRNA expression pattern of the other 
MHC isoforms. If IUGR were to favor a glycolytic fiber type, it could be expected to see 
an increase in MHC 7 or MHC 2 in LBW/WD animals. The fact this was not the case 
could be explained by noting my data is at the mRNA level and these results could 
therefore a compensatory mechanism in the event that translation of these messages is 
downregulated. Furthermore, mRNA expression of MHC isoforms does not support the 
results of the citrate synthase activity assay, which suggests similar functional 
mitochondrial number across all groups. If the fiber types differ between groups as the 
mRNA would suggest, mitochondrial activity would be expected to differ between 
groups as well given that mitochondrial density is dictated by fiber type. Studies in 
rabbits and chicks found differences in CS activity between muscle groups considered to 
be of different fiber types (Howlett and Willis, 1998; Hakamata et al., 2018) however a 
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study in highly trained athletes suggests that CS activity does not change with MHC 
isoform expression (Ørtenblad et al., 2018) therefore CS activity alone cannot be used as 
a good marker for fiber type composition. 
Many studies have shown that a high-fat diet increases protein expression of glycolytic 
fiber compared to oxidative fibers (Tanner et al., 2002; Ten Broek et al., 2010). While 
my mRNA data do not agree with these observations, we speculate that translational and 
post-translational regulation may determine fiber types composition for both diet and 
IUGR treatments. Further studies identifying protein expression of the MHC isoforms are 
needed to determine if fiber type is truly altered or if there is only a change in 
mitochondrial function rather than number as my CS assay would suggest (figure 3.2-5).  
 
4.4 Hypoxic Regulation of C2C12 Oxygen Consumption  
 
Hypoxia has been identified as a contributing factor influencing placental insufficiency 
and growth restriction (Genbacev et al., 1997; Thornburg and Louey, 2005; Ream et al., 
2008; Yinon et al., 2008; Tal et al., 2010). Oxygen homeostasis is critical to cellular 
function as oxygen availability plays a key role in oxidative phosphorylation, the process 
responsible for producing the majority of ATP. HIF-1α degradation is regulated by 
cellular oxygen concentration (Wang et al., 1995) and alters metabolic gene expression. 
Under normoxic conditions, HIF-1 α is degraded by hydroxylation of two proline 
residues in the oxygen-dependent degradation domain, which does not occur in hypoxia 
(Wang et al., 1995). When HIF-1 α is not degraded it dimerizes with HIF-1β  which 
transcriptionally activates anaerobic, glycolytic enzymes phosphoglycerate kinase 1 and 
pyruvate kinase (PDK1; Kim et al., 2006). Increased availability of HIF-1α is associated 
with increased activation of PDK1 (Kim et al., 2006), a kinase that reduces pyruvate 
entry into the TCA cycle by inhibitory phosphorylation of pyruvate dehydrogenase. By 
inhibiting pyruvate entry into the TCA cycle, there is a decrease in NADH and FADH 
production when oxidizing carbohydrates and a corresponding decrease in ATP 
54 
 
production via OXPHOS, unless increased FA oxidation can compensate. Low cellular 
oxygen availability therefore results in increased anaerobic ATP through glycolysis and 
decreased aerobic ATP production from OXPHOS. The persistent reduction in rates of 
oxygen consumption seen in figure 3.4-1 during recovery, when provided with glucose as 
a substrate, is indicative of a reprograming event; after the hypoxic insult is removed, its 
decreased glucose oxidation capacity is still present. These data suggest a hypoxic in 
utero environment may result in permanently altered skeletal muscle metabolism. 
 
4.5 Impact of Fatty Acids on Oxygen Consumption of 
Hypoxic Cultured Cells 
 
To further assess the effects of hypoxia in utero, a second insult of saturated fatty acid 
palmitate was added to the media of cells recovering from hypoxia, I used palmitate as it 
is a prevalent SFA found in the WD. The saturated fatty acid reduces the oxygen 
consumption of normoxic cultured cells by 47% compared to BSA controls, whereas it 
had no effect on hypoxic cultured cells when given glucose as a substrate. SFAs are 
associated with decreased oxidative metabolism in heathy skeletal muscle (Gao et al., 
2011), consistent with results in Figure 3.3-2. Furthermore, a rat study found that 
palmitate promotes oxidative stress and apoptosis in hepatocytes indicating that dietary 
SFAs may alter oxidative metabolism by altering either reactive oxygen species 
production of detoxification (Egnatchik et al., 2014). Of interest, however; is the lack of 
further decrease in oxygen consumption in the group treated with both hypoxia and SFA, 
which may indicate that hypoxia reduces OXPHOS to minimal functional levels. 
Conversely, palmitoleate a monounsaturated fatty acid which has the same number of 
carbons as palmitoleate and is necessary for cellular structure and function did not have 
any inhibitory or stimulatory effects on oxygen consumption of either normoxic or 
hypoxic cultured cells. By contrast palmitoleate has been found to increase oxygen 
consumption in white adipocytes (Cruz et al., 2018).  
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4.6 Potential Limitations 
 
All studies have limitations and must be acknowledged. First, the animal and cell culture 
models present limitations of their own.  The C2C12 mouse myoblast model, while 
excellent for the isolation of hypoxic effects during myoblast differentiation, is limited in 
a few ways. First, the cell line is an adult cell line but it was used to simulate in utero 
differentiation. I used these cells because methods concerning hypoxic differentiation and 
fatty acid treatments are well established. Second, the C2C12 cell line does not permit 
studies of longevity. Cell viability declines past 7 days following differentiation therefore 
long-term effects of hypoxia on skeletal muscle differentiation could not be determined in 
the present study. Furthermore, oxygen tensions representing physiological normoxia 
(5%, 38mmHg) and hypoxia (1%, 7.6mmHg) were chosen based on experimental 
umbilical cord data (Wilkening and Meschia, 1992; Regnault et al., 2007). Oxygen 
tensions in skeletal muscle is variable, a study found the mean PO2 of 4mmHg in 
intracellular guinea pig muscle (Whalen and Nair, 1967).    
Finally, this study is limited in its determination of skeletal muscle fiber type composition 
as mRNA expression was measured. Protein expression would have provided a clearer 
understanding of the soleus muscle fiber type as it is defined by the isoform of MHC 
protein expressed (Tanner et al., 2002; Ten Broek et al., 2010). Unfortunately, I was 
unable to successfully bind available MHC antibodies to cross-react with my tissue 
samples. Comparing MHC isoform protein expression with my CS activity and oxygen 
consumption would present a clearer idea of whether and how muscle fiber type 
composition is affected by IUGR and post-natal diet.     
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4.7 Future Studies 
 
In this study I present evidence which supports that both an adverse in utero environment 
and hypoxic specific insults negatively affect skeletal muscle oxygen consumption. 
Additionally, I provide evidence that the postnatal diet, one high in fats also impairs 
muscle oxidative function. Specifically, I have identified that both a reduction in complex 
I protein expression and activity are related to both birthweight and diet. With that 
identified, the next logical progression is to identify and implement potential rescue 
treatments.  
As previously mentioned, fiber type determination was unclear and inconsistent with my 
CS activity assay. Future studies should investigate the protein expression of MHC 
isoforms to identify if there is a marked shift in SM fiber type composition. Furthermore, 
previous studies have found a shift towards a more glycolytic fiber type in animals with 
IR and type 2 diabetes, thus it would be valuable to determine in a longitudinal study if  
similar findings are observed with my model, as my 4-month-old animals do not yet 
exhibit signs of such metabolic disorders (data not shown).  
In my cell culture studies, I found that the SFA palmitate reduced oxygen consumption in 
normoxic cells and that the MUFA palmitoleate failed to rescue oxygen consumption in 
hypoxic cells. Treatments with PUFAs should be explored as they have been identified as 
potentially beneficial to metabolism in other studies. Also, molecular analyses of specific 
enzymes responsible for the observed decrease in oxygen consumption as a response to 
SFA exposure would facilitate the identification of potential treatment targets such as 
antioxidants.  
  
57 
 
4.8 Conclusions 
 
In summary the results support my first hypothesis; SM oxygen consumption is decreased 
in LBW fetal guinea pigs compared to NBW animals (figure 3.2-1). Interestingly, 
reduced oxygen consumption in LBW fetal guinea pigs is observed following pyruvate 
administration but not glutamate both of which are reduced in 4-month-old animals 
(figure 3.2-2) and both metabolized by complex I of the ETC. The discordance in 
glutamate metabolism between fetal and 4-month-old animals may be explained by an 
adaptive response of lower GDH expression in low oxygen conditions (Jozwik et al., 
2009). The observed decrease in NDUF8 expression further supports these findings (3.2-
4). Furthermore, it is of note that succinate metabolism was unaffected by birth-weight 
(Figure 3.2-1), suggesting complex II function remains intact in UAA animals, which is 
consistent in 4-month-old animals (Figure 3.2-2). Together, these results support an in 
utero reprograming event in response to PI resulting in decreased expression and activity 
of complex I and reduced oxidative capacity. Similar overall reductions in skeletal 
muscle oxidation have been linked to insulin resistance and type 2 diabetes (He et al., 
2001; Selak et al., 2003). These findings may be a physiological contributor to the 
observed correlation between low birth weight and later-onset metabolic disorders such 
as insulin resistance and type 2 diabetes (Simmons et al., 2001; Barker, 2004; Valsamakis 
et al., 2006). 
When measuring soleus oxygen consumption, no further reduction in rate of oxygen 
consumption was observed when comparing LBW animals on a control diet to LBW 
animals on a Western diet. Perhaps the more intriguing result is that the Western diet had 
a similar effect to the LBW further emphasizing that this physiological response of 
reduced oxygen consumption plays an important role in uncovering the link between 
IUGR and metabolic disorders, given that the Western diet is a primary contributor in the 
development of IR, type 2 diabetes and other metabolic diseases (Wirfalt et al., 2001; 
James et al., 2004; Cordain et al., 2005). Given the common outcome of reduced oxygen 
consumption in both LBW and WD groups, both are forms of oxidative stress which I 
found to target complex I (figure 3.2-4). 
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In contrast to my postulation, I did not observe a clear link between fiber type 
composition and hypoxia (figure 3.3-4), however; fiber type was studied at the messenger 
level and not as protein expression. While an increased proportion of glycolytic fibers is 
associated with obesity and type 2 diabetes (He et al., 2001; Tanner et al., 2002) it was 
not supported at the mRNA level following a WD or in LBW animals. Moreover, CS 
activity did not differ between these groups (figure 3.2-5) further supporting that these 
animals do not differ in fiber type composition. However, these fiber type results should 
be confirmed by protein analysis in order to rule out a possible correlation between LBW 
and fiber type composition. 
Lastly, the hypoxia-specific cell culture experiments supported the hypotheses: cells 
cultured under hypoxic conditions had lower rates of oxygen consumption even 
following re-oxygenation (figure 3.4-2) suggesting that hypoxic exposure during 
differentiation leads to persistent reductions in oxygen consumption, within the time 
period studied. As predicted, the addition of saturated fatty acid palmitate reduced 
oxygen consumption in normoxic cultured cells but had no further negative effects on 
hypoxic cultured cells (figure 3.4-3) which is consistent with the data obtained from the 
guinea pig offspring studies. It appears that both the hypoxic insult and diet insult 
produce similar effects, but interestingly are not additive, suggesting perhaps a lower 
threshold for oxygen consumption in skeletal muscle is reached with either insult. Unlike 
the saturated fatty acid treatment, monounsaturated fatty acids did not yield the 
anticipated results: palmitoleate did not significantly affect oxygen consumption (figure 
3.4-3). These results suggest that a diet rich in monounsaturated fatty acids will not 
mitigate the reduction in oxygen consumption resulting from hypoxia during 
differentiation and that other treatments should be explored. 
All together the results of the above described studies suggest that hypoxia in utero is a 
potential mechanism for predisposition to MS with similar but not additive effects of a 
WD. This study identified that IUGR and a post-natal WD both independently reduce 
skeletal muscle oxygen consumption which may contribute to the observed link between 
an adverse in utero environment and the development of adult-onset metabolic disorders.  
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AUP Number: 2010-229 
PI Name: Regnault, Timothy 
AUP Title: In Utero Origins of Adult Insulin Resistance 
Approval Date: 09/08/2014 
Official Notice of Animal Use Subcommittee (AUS) Approval: Your new 
Animal Use Protocol (AUP) entitled "In Utero Origins of Adult Insulin 
Resistance" has been APPROVED by the Animal Use Subcommittee of the 
University Council on Animal Care. This approval, although valid for four years, 
and is subject to annual Protocol Renewal.2010-229::5 
 
1 This AUP number must be indicated when ordering animals for this project. 
2 Animals for other projects may not be ordered under this AUP number. 
3 Purchases of animals other than through this system must be cleared through the ACVS 
office. Health certificates will be required. 
 
The holder of this Animal Use Protocol is responsible to ensure that all associated 
safety components (biosafety, radiation safety, general laboratory safety) comply 
with institutional safety standards and have received all necessary approvals. 
Please consult directly with your institutional safety officers. 
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